CNS THERAPEUTICS INC — Form D/A
CNS THERAPEUTICS INC of ST. PAUL, MN, a company, filed a Form D amendment with the SEC on 2011-04-28. The offering totals $3.0M, of which $3.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2011-04-28
- Form: D/A
- Accession: 0001439036-11-000003
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $3.0M
- Amount sold: $3.0M
- Investors: 7
- Date of first sale: 2010-12-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-152901
Issuer
- Name: CNS THERAPEUTICS INC
- CIK: 0001439036
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 332 MINNESOTA STREET, ST. PAUL, MN, 55101
- Phone: 651 207 6959
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| John Foster | Director | New York, NY |
| Nina Kjellson | Director | Santa Clara, CA |
| Peter McNerney | Director | Boston, MA |
| Howard Rosen | Director | Woburn, MA |
| Pratik Shah | Director | George Town, Grand Cayman, E9 |
| John Foster | Executive Officer | New York, NY |
| Andrew LaFrence | Executive Officer | Maple Grove, MN |
| Richard Penn | Executive Officer | Vancouver, A1 |
| John Foster | Promoter | New York, NY |
| Andrew LaFrence | Promoter | Maple Grove, MN |
| Richard Penn | Promoter | Vancouver, A1 |
| Scott Bronson | Executive Officer | St. Paul, MN |
| Scott Bronson | Promoter | St. Paul, MN |
Other filings by this issuer (2)
More